Diabetes

January 15, 2019

Molecular therapy for diabetes: Estrogen receptor-β (ER-β) increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of its target gene Lin28, 15/January/2019, 11.01 pm

Molecular therapy for diabetes: Estrogen receptor-β (ER-β) increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of its target gene Lin28, 15/January/2019, 11.01 pm https://genomediscovery.org/wp-content/uploads/2019/01/ERbeta-increases-the-expression-of-Lin28-augments-insulin-secretion-and-sensitivity-promotes-glucose-tolerance-and-attenuates-the-development-of-diabetes-1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/01/ERbeta-increases-the-expression-of-Lin28-augments-insulin-secretion-and-sensitivity-promotes-glucose-tolerance-and-attenuates-the-development-of-diabetes-1.jpg January 15, 2019 January 15, 2019

Introduction: What they say: A study from the Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA shows that “The Lin28/let-7 axis regulates glucose metabolism.” This study…

January 13, 2019

Molecular therapy for diabetes: Runx2/AML1 increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of its target gene Lin28, 13/January/2019, 11.37 pm

Molecular therapy for diabetes: Runx2/AML1 increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of its target gene Lin28, 13/January/2019, 11.37 pm https://genomediscovery.org/wp-content/uploads/2019/01/Runx2-or-AML1-increases-the-expression-of-Lin28-augments-insulin-secretion-and-sensitivity-promotes-glucose-tolerance-and-attenuates-the-development-of-diabetes.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/01/Runx2-or-AML1-increases-the-expression-of-Lin28-augments-insulin-secretion-and-sensitivity-promotes-glucose-tolerance-and-attenuates-the-development-of-diabetes.jpg January 13, 2019 January 13, 2019

January 12, 2019

Ribonucleic acid-based therapy for diabetes: LncRNA PVT1-214 increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of its target gene Lin28, 12/January/2019, 8.37 am

Ribonucleic acid-based therapy for diabetes: LncRNA PVT1-214 increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of its target gene Lin28, 12/January/2019, 8.37 am https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-PVT1214-increases-the-expression-of-Lin28-augments-insulin-secretion-and-sensitivity-promotes-glucose-tolerance1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/01/LncRNA-PVT1214-increases-the-expression-of-Lin28-augments-insulin-secretion-and-sensitivity-promotes-glucose-tolerance1.jpg January 12, 2019 January 12, 2019

January 12, 2019

Repurposing the anti-hypertensive agent Manidipine into an anti-diabetic agent: Manidipine (Trade name: Manyper), an antihypertensive agent, increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of its target gene Lin28, 12/January/2019, 7.14 am

Repurposing the anti-hypertensive agent Manidipine into an anti-diabetic agent: Manidipine (Trade name: Manyper), an antihypertensive agent, increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of its target gene Lin28, 12/January/2019, 7.14 am https://genomediscovery.org/wp-content/uploads/2019/01/Manidipine-protects-against-insulin-resistance-myocardial-infarction-diabetic-cardiomyopathy-through-up-regulation-of-reprogramming-protein-Lin28.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/01/Manidipine-protects-against-insulin-resistance-myocardial-infarction-diabetic-cardiomyopathy-through-up-regulation-of-reprogramming-protein-Lin28.jpg2_.jpg January 12, 2019 January 12, 2019

January 8, 2019

Ribonucleic acid-based therapy for glucose homeostasis and TIIDM: LncRNA H19 increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM, via down regulation of its target gene, 9/January/2019, 12.19 am

Ribonucleic acid-based therapy for glucose homeostasis and TIIDM: LncRNA H19 increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM, via down regulation of its target gene, 9/January/2019, 12.19 am https://genomediscovery.org/wp-content/uploads/2019/01/LnRNA-H19-acts-as-an-anti-diabetic-agent-by-increasing-Pax6-expression.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/01/LnRNA-H19-acts-as-an-anti-diabetic-agent-by-increasing-Pax6-expression.jpg2_.jpg January 8, 2019 January 8, 2019

Introduction: What they say A study from the Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel shows that…

January 8, 2019

Repurposing the anti-hypertensive agent Felodipine into an anti-diabetic agent: Felodipine (Trade name: Plendil), an antihypertensive agent, increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of its target gene Lin28, 9/January/2019, 12.12 am

Repurposing the anti-hypertensive agent Felodipine into an anti-diabetic agent: Felodipine (Trade name: Plendil), an antihypertensive agent, increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of its target gene Lin28, 9/January/2019, 12.12 am https://genomediscovery.org/wp-content/uploads/2019/01/Felodipine-protects-against-insulin-resistance-myocardial-infarction-diabetic-cardiomyopathy-through-up-regulation-of-reprogramming-protein-Lin28.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2019/01/Felodipine-protects-against-insulin-resistance-myocardial-infarction-diabetic-cardiomyopathy-through-up-regulation-of-reprogramming-protein-Lin28.jpg January 8, 2019 January 8, 2019

Molecular therapy for diabetes: Estrogen receptor-β (ER-β) increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of its target gene Lin28, 15/January/2019, 11.01 pm

Molecular therapy for diabetes: Runx2/AML1 increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of its target gene Lin28, 13/January/2019, 11.37 pm

Ribonucleic acid-based therapy for diabetes: LncRNA PVT1-214 increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of its target gene Lin28, 12/January/2019, 8.37 am

Popular Post